Ignite Creation Date:
2025-12-25 @ 3:07 AM
Ignite Modification Date:
2025-12-31 @ 10:22 PM
Study NCT ID:
NCT05751733
Status:
RECRUITING
Last Update Posted:
2023-03-02
First Post:
2023-02-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
Sponsor:
Xiangya Hospital of Central South University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
XYGIST202202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |